Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Oncology Institute Inc logo

Oncology Institute Inc

US$4.59

US$458.9m

14.75%

74.86%

Dashboard Funda..tals Deep..lue Prediction Screener Map

Oncology Institute Inc Overview

Industry: Medical Care Facilities

Sector: Healthcare

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Oncology Institute Inc is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review Oncology Institute Inc in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



Oncology Institute Inc Competitors

Oncology Institute Inc operates in the Medical Care Facilities industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

Oncology Institute Inc

US$4.59

US$458.9m

14.75%

74.86%